BioCentury
ARTICLE | Company News

Astellas, Leo Pharma deal

November 16, 2015 8:00 AM UTC

Leo Pharma will acquire the global dermatology business of Astellas for EUR675 million ($726.6 million). Astellas’ dermatology portfolio includes Protopic, a topical formulation of the immunosuppressant tacrolimus to treat eczema, and Locoid hydrocortisone butyrate for dermatitis. ...